151 related articles for article (PubMed ID: 20396943)
1. RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects.
Wang Z; Dong H; Fu Y; Ding H
Breast Cancer Res Treat; 2010 Dec; 124(3):765-9. PubMed ID: 20396943
[TBL] [Abstract][Full Text] [Related]
2. RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies.
Gao LB; Pan XM; Li LJ; Liang WB; Zhu Y; Zhang LS; Wei YG; Tang M; Zhang L
Breast Cancer Res Treat; 2011 Feb; 125(3):827-35. PubMed ID: 20640595
[TBL] [Abstract][Full Text] [Related]
3. 135G>C and 172G>T polymorphism in the 5' untranslated region of RAD51 and sporadic endometrial cancer risk in Polish women.
Smolarz B; Samulak D; Michalska M; Góralczyk B; Szyłło K; Lewy J; Sporny S; Kokołaszwili G; Burzyński M; Romanowicz-Makowska H
Pol J Pathol; 2011 Sep; 62(3):157-62. PubMed ID: 22102073
[TBL] [Abstract][Full Text] [Related]
4. NBS1 8360G > C polymorphism is associated with breast cancer risk: a meta-analysis.
Wang Z; Cui D; Lu W
Breast Cancer Res Treat; 2010 Sep; 123(2):557-61. PubMed ID: 20143155
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer.
Krupa R; Synowiec E; Pawlowska E; Morawiec Z; Sobczuk A; Zadrozny M; Wozniak K; Blasiak J
Exp Mol Pathol; 2009 Aug; 87(1):32-5. PubMed ID: 19426727
[TBL] [Abstract][Full Text] [Related]
6. 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant.
Lu J; Wang LE; Xiong P; Sturgis EM; Spitz MR; Wei Q
Carcinogenesis; 2007 May; 28(5):988-94. PubMed ID: 17118968
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51.
Silva SN; Tomar M; Paulo C; Gomes BC; Azevedo AP; Teixeira V; Pina JE; Rueff J; Gaspar JF
Cancer Epidemiol; 2010 Feb; 34(1):85-92. PubMed ID: 20004634
[TBL] [Abstract][Full Text] [Related]
8. RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population.
Jara L; Acevedo ML; Blanco R; Castro VG; Bravo T; Gómez F; Waugh E; Peralta O; Cabrera E; Reyes JM; Ampuero S; González-Hormazábal P
Cancer Genet Cytogenet; 2007 Oct; 178(1):65-9. PubMed ID: 17889711
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the G/C polymorphism in the 5'-untranslated region of the RAD51 gene in breast cancer.
Blasiak J; Przybyłowska K; Czechowska A; Zadrozny M; Pertyński T; Rykała J; Kołacińska A; Morawiec Z; Drzewoski J
Acta Biochim Pol; 2003; 50(1):249-53. PubMed ID: 12673366
[TBL] [Abstract][Full Text] [Related]
10. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
11. Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.
Qiu LX; Yao L; Mao C; Yu KD; Zhan P; Chen B; Yuan H; Zhang J; Xue K; Hu XC
Breast Cancer Res Treat; 2010 Jul; 122(2):521-5. PubMed ID: 20054636
[TBL] [Abstract][Full Text] [Related]
12. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
13. Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects.
Yu KD; Di GH; Fan L; Chen AX; Yang C; Shao ZM
Breast Cancer Res Treat; 2010 Jul; 122(2):483-8. PubMed ID: 20043205
[TBL] [Abstract][Full Text] [Related]
14. RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies.
Yu KD; Yang C; Fan L; Chen AX; Shao ZM
Breast Cancer Res Treat; 2011 Apr; 126(2):365-71. PubMed ID: 20461453
[TBL] [Abstract][Full Text] [Related]
15. Germline BRCA1 mutations and G/C polymorphism in the 5'-untranslated region of the RAD51 gene in Polish women with breast cancer.
Romanowicz-Makowska H; Smolarz B; Kulig A
Pol J Pathol; 2005; 56(4):161-5. PubMed ID: 16477874
[TBL] [Abstract][Full Text] [Related]
16. Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.
Yao L; Yu X; Yu L
Breast Cancer Res Treat; 2010 Jul; 122(2):503-7. PubMed ID: 20052535
[TBL] [Abstract][Full Text] [Related]
17. RAD51 135G>C substitution increases breast cancer risk in an ethnic-specific manner: a meta-analysis on 21,236 cases and 19,407 controls.
Sekhar D; Pooja S; Kumar S; Rajender S
Sci Rep; 2015 Jun; 5():11588. PubMed ID: 26108708
[TBL] [Abstract][Full Text] [Related]
18. Variants in DNA double-strand break repair genes and risk of familial breast cancer in a South American population.
Jara L; Dubois K; Gaete D; de Mayo T; Ratkevicius N; Bravo T; Margarit S; Blanco R; Gómez F; Waugh E; Peralta O; Reyes JM; Ibáñez G; González-Hormazábal P
Breast Cancer Res Treat; 2010 Aug; 122(3):813-22. PubMed ID: 20054644
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility.
Ding SL; Yu JC; Chen ST; Hsu GC; Kuo SJ; Lin YH; Wu PE; Shen CY
Carcinogenesis; 2009 Jan; 30(1):43-9. PubMed ID: 18974064
[TBL] [Abstract][Full Text] [Related]
20. The association of SULT1A1 codon 213 polymorphism and breast cancer susceptibility: meta-analysis from 16 studies involving 23,445 subjects.
Sun Y; Zang Z; Xu X; Zhang Z; Zhong L; Zan W; Zhao Y; Sun L
Breast Cancer Res Treat; 2011 Jan; 125(1):215-9. PubMed ID: 20505990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
